These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8475635)

  • 1. [Differential therapy with oral antidiabetic drugs].
    Sachse G
    Z Gesamte Inn Med; 1993 Mar; 48(3):127-9. PubMed ID: 8475635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy of oral antidiabetic drugs with insulin].
    Lotz N; Bachmann W
    Z Gesamte Inn Med; 1993 Mar; 48(3):130-4. PubMed ID: 8475636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs].
    Landgraf R
    MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
    Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
    Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II diabetes: how to use the new oral medications. Interview by David B. Jack.
    Bohannon NJ
    Geriatrics; 1996 Apr; 51(4):33-7. PubMed ID: 8626076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
    Mehnert H
    Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Step-wise drug therapy in type 2 diabetes mellitus].
    König K; Schatz H
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of type II diabetes mellitus.
    Baliga BS; Fonseca VA
    Am Fam Physician; 1997 Feb; 55(3):817-24. PubMed ID: 9048504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of body weight during antidiabetic treatment].
    Hamann A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S; Alvarsson M; Brismar K; Wagner H
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.